Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial
David R. Freyer(University of Southern California), Lillian Sung(Hospital for Sick Children), David Van Hoff(Helen DeVos Children's Hospital), Doojduen Villaluna(Apple (Israel)), Jagadeesh Ramdas(Geisinger Medical Center), Michele L VanSoelen(Helen DeVos Children's Hospital), Kristin R. Knight(Great Ormond Street Hospital), Mark Krailo(Arcadia), Brad H. Pollock(The University of Texas at San Antonio Health Science Center), Lu Chen(Children's Oncology Group), B P Bliss(Children's Oncology Group), Edward A. Neuwelt(Oregon Health & Science University), Beverly J. Lange(Philadelphia University), John Wiernikowski(McMaster University)
Cited by 255
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586